Neuroblastoma mRNAs Predict Outcome in Children With Stage 4 Neuroblastoma: A European HR-NBL1/SIOPEN Study | Zendy

Virginie Viprey | Zendy; Walter M. Gregory | Zendy; Maria Valeria Corrias | Zendy; Andréï Tchirkov | Zendy; Katrien Swerts | Zendy; Aleš Vícha | Zendy; Sandro Dallorso | Zendy; Penelope Brock | Zendy; Roberto Luksch | Zendy; Dominique ValteauCouanet | Zendy; Vassilios Papadakis | Zendy; Geneviève Laureys | Zendy; Andrew D.J. Pearson | Zendy; Ruth Ladenstein | Zendy; Susan A. Burchill | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Neuroblastoma mRNAs Predict Outcome in Children With Stage 4 Neuroblastoma: A European HR-NBL1/SIOPEN Study

Author(s) -

Virginie Viprey,

Walter M. Gregory,

Maria Valeria Corrias,

Andréï Tchirkov,

Katrien Swerts,

Aleš Vícha,

Sandro Dallorso,

Penelope Brock,

Roberto Luksch,

Dominique ValteauCouanet,

Vassilios Papadakis,

Geneviève Laureys,

Andrew D.J. Pearson,

Ruth Ladenstein,

Susan A. Burchill

Publication year - 2014

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2013.53.3604

Subject(s) - neuroblastoma , medicine , stage (stratigraphy) , cohort , oncology , gastroenterology , cancer research , biology , cell culture , paleontology , genetics

To evaluate the hypothesis that detection of neuroblastoma mRNAs by reverse transcriptase quantitative polymerase chain reaction (RTqPCR) in peripheral blood (PB) and bone marrow aspirates (BM) from children with stage 4 neuroblastoma are clinically useful biomarkers of risk.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research